Evommune, Inc. (EVMN) News
Latest headlines that mention EVMN, newest first · each headline opens the original publisher
- Last price
- $6.04
- Day change
- +1.68%
- Next earnings
- 2026-12-10
EVMN headlines
latest coverageEvommune stock dropped Wednesday after its experimental eczema treatment flopped in midstage testing. The bearish news followed another miss for the drug in treating hives. The post This Biotech Has Lost 50%-Plus On Just One Drug; Why It's Still Trucking On appeared first on…
EVMN news alerts
Get an alert by email or push when a new headline mentions EVMN.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.